Management and Outcomes of Critically-Ill Patients with COVID-19 Pneumonia at a Safety-net Hospital in San Francisco, a Region with Early Public Health Interventions: A Case Series
Vanderburg, S.; Alipanah, N.; Crowder, R.; Yoon, C.; Wang, R.; Thakur, N.; Slown, K.; Shete, P. B.; Rofael, M.; Metcalfe, J. Z.; Merrifield, C.; Marquez, C.; Malcolm, K.; Lipnick, M.; Jain, V.; Gomez, A.; Burns, G.; Brown, L. B.; Berger, C.; Auyeung, V.; Cattamanchi, A.; Hendrickson, C. M.
Show abstract
BackgroundFollowing early implementation of public health measures, San Francisco has experienced a slow rise and a low peak level of coronavirus disease 2019 (COVID-19) cases and deaths. Methods and FindingsWe included all patients with COVID-19 pneumonia admitted to the intensive care unit (ICU) at the safety net hospital for San Francisco through April 8, 2020. Each patient had [≥]15 days of follow-up. Among 26 patients, the median age was 54 years (interquartile range, 43 to 62), 65% were men, and 77% were Latinx. Mechanical ventilation was initiated for 11 (42%) patients within 24 hours of ICU admission and 20 patients (77%) overall. The median duration of mechanical ventilation was 13.5 days (interquartile range, 5 to 20). Patients were managed with lung protective ventilation (tidal volume [≤]8 ml/kg of ideal body weight and plateau pressure [≤]30 cmH2O on 98% and 78% of ventilator days, respectively). Prone positioning was used for 13 of 20 (65%) ventilated patients for a median of 5 days (interquartile range, 2 to 10). Seventeen (65%) patients were discharged home, 1 (4%) was discharged to nursing home, 3 (12%) were discharged from the ICU, and 2 (8%) remain intubated in the ICU at the time of this report. Three (12%) patients have died. ConclusionsGood outcomes were achieved in critically ill patients with COVID-19 by using standard therapies for acute respiratory distress syndrome (ARDS) such as lung protective ventilation and prone positioning. Ensuring hospitals can deliver sustained high-quality and evidence-based critical care to patients with ARDS should remain a priority.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- ICU Outcomes and Survival in Patients with Severe COVID-19 in the Largest Health Care System in Central Florida 93%
- Observational study of changes in utilization and outcomes in non-invasive ventilation in COVID-19 92%
- Derivation and validation of a triage tool for acutely ill adults with suspected COVID-19: The PRIEST observational cohort study 92%
Similar papers in this journal
- Antibiotic Use and Outcomes in Young Children Hospitalized with Uncomplicated Community-Acquired Pneumonia 93%
- Diagnostic utility of a Ferritin-to-Procalcitonin Ratio to differentiate patients with COVID-19 from those with Bacterial Pneumonia: A multicenter study 92%
- Reduction in risk of death among patients admitted with COVID-19 between first and second epidemic waves in New York City 90%
Similar papers in this journal
- Exploring Associations with Severe Hypoxemic Respiratory Failure in COVID-19 Patients upon Admission: A Model for Severe Hypoxemic Respiratory Failure in 329 Unvaccinated, Hospitalized COVID-19 Patients 93%
- Towards definitions of critical illness and critical care using concept analysis 92%
- Helmet noninvasive ventilation for COVID-19 patients (Helmet-COVID): study protocol for a multicenter randomized controlled trial 91%
Similar papers in this journal
- COVID-19 Hospitalizations in Five California Hospitals 91%
- Clinical Features and Predictors for Patients with Severe SARS-CoV-2 Pneumonia: a retrospective multicenter cohort study 90%
- Association between SARS-CoV-2 Infection and Select Symptoms and Conditions 31 to 150 Days After Testing among Children and Adults 89%
Similar papers in this journal
- Detection of RSV using nasopharyngeal swabs alone underestimates RSV-related hospitalization incidence in adults: the Multispecimen study’s Final Analysis 88%
- Plasma SARS-CoV-2 RNA levels as a biomarker of lower respiratory tract SARS-CoV-2 infection in critically ill patients with COVID-19 87%
- Real World Evidence of the Neutralizing Monoclonal Antibody Sotrovimab for Preventing Hospitalization and Mortality in COVID-19 Outpatients 86%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.